The cytochrome bd quinol oxidase is one of two respiratory oxidases in Escherichia coli. It oxidizes dihydroubiquinol or dihydromenaquinol while reducing dioxygen to water. The bd-type oxidases have only been found in prokaryotes and have been implicated in the survival of some bacteria, including pathogens, under conditions of low aeration. With a high affinity for dioxygen, cytochrome bd not only couples respiration to the generation of a proton motive force but also scavenges O 2 . In the current work, the role of a highly conserved arginine residue is explored by site-directed mutagenesis. Four mutations were made: R391A, R391K, R391M, and R391Q. All of the mutations except R391K result in enzyme lacking ubiquinol oxidase activity. Oxidase activity using the artificial reductant N,N,N,N-tetramethylp-phenylenediamine in place of ubiquinol was, however, unimpaired by the mutations, indicating that the catalytic center where O 2 is reduced is intact. UV-visible spectra of each of the mutant oxidases show no perturbations to any of the three heme components (heme b 558 , heme b 595 , and heme d). However, spectroelectrochemical titrations of the R391A mutant reveal that the midpoint potentials of all of the heme components are substantially lower compared with the wild type enzyme. Since Arg 391 is close to Met 393 , one of the axial ligands to heme b 558 , it is to be expected that the R391A mutation might destabilize the reduced form of heme b 558 . The fact that the midpoint potentials of heme d and heme b 595 are also significantly lowered in the R391A mutant is consistent with these hemes being physically close together on the periplasmic side of the membrane.
The cytochrome bd respiratory oxidase has a very high affinity for O 2 (in nM range) and is found in many prokaryotes (1) (2) (3) (4) . The bd-type oxidases are being increasingly recognized as physiologically significant. Frequently, these respiratory oxidases are induced under conditions of very low aeration, either to generate a proton motive force by reducing O 2 to water or by scavenging O 2 to protect the cell (5, 6) . For example, cytochrome bd was recently found in what were previously identified as strict anaerobes, Bacteroides fragilis (7) and Desulfovibrio gigas (8) , which allowed these organisms to grow aerobically with very low concentrations of O 2 . Mutations in the enzyme have been implicated in reduced virulence in some pathogens (9, 10) . Although cytochrome bd catalyzes the twoelectron oxidation of either ubiquinol or menaquinol and the reduction of O 2 to water, cytochrome bd is completely unrelated to the proton-pumping heme/copper superfamily of respiratory oxidases. Indeed, the bd-type oxidases do not pump protons, although they do generate a proton motive force (11, 12 ). It appears that quinol oxidation occurs near the periplasmic surface (13) (14) (15) but that the protons used to form water are taken from the bacterial cytoplasm. Hence, the reaction is coupled to transmembrane charge separation and the generation of a membrane potential.
The best characterized bd-type oxidase is from E. coli (1, 2) . The enzyme is a heterodimer with one copy each of two subunits (CydA and CydB). There are three heme prosthetic groups but no copper. Heme b 558 is ligated to His 186 and Met 393 in CydA (see Fig. 1 ) (16, 17) and appears to be directly involved in the oxidation of quinol (18) . Heme b 595 and heme d are both high spin hemes that appear to form a binuclear center where O 2 is reduced to water (19) . It is known that O 2 binds to ferrous heme d and, in the absence of additional reducing equivalents, forms a stable heme d Fe 2ϩ -O 2 adduct. The axial ligand of heme b 595 has been identified as His 19 in CydA (20, 21) (Fig. 1 ), but the nature and location of the axial ligand to heme d are not known.
In the current work, the role of Arg 391 in the CydA subunit of the Escherichia coli oxidase is investigated. This arginine is very highly conserved and is only two residues away from Met 393 , one of the axial ligands to heme b 558 (Fig. 1) . It was expected, therefore, that this residue might play either a structural or functional role related to heme b 558 or the putative quinol binding site that is proposed to be adjacent to this heme (1, 22) . Four site-directed mutants were made: R391K, R391A, R391Q, and R391M. The R391K mutant oxidase is partially active as a quinol oxidase (25% of wild type activity), but the other three uncharged amino acid substitutions all result in eliminating quinol oxidase activity. The optical spectrum of each of the enzymes is normal, indicating that the hemes are properly assembled and there is no major conformational change. All of the mutants are active using an alternative artificial substrate TMPD, 1 which has previously been characterized as utilizing a different site from that of ubiquinol (23) . This indicates that the O 2 binding site and catalytic function * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
are not perturbed by the Arg 391 mutants. The major effect of the R391A mutation (and presumably the R391Q and R391M substitutions) is to decrease the electrochemical midpoint potential of heme b 558 , which is sufficient to explain the lack of quinol oxidase activity. The positive charge on Arg 391 appears to stabilize the reduced form of heme b 558 in the E. coli oxidase by about 210 mV (ϩ80 mV versus Ϫ130 mV). Substitution by another amino acid residue, other than lysine, makes it much harder to reduce heme b 558 and inactivates the enzyme. Remarkably, the R391A mutant also results in a lower potential for both heme b 595 and heme d. If this is due simply to an electrostatic effect, all of the hemes must be physically close to Arg 391 . A local conformational change due to the R391A mutation cannot be ruled out as the cause of the lower midpoint potentials of hemes b 595 and d. However, this is unlikely, since the optical and EPR spectra appear unperturbed, and the TMPD oxidase activity is unimpaired.
MATERIALS AND METHODS
Strains and Plasmids-E. coli strain GO105 (cyd AB::kan, cyo, recA), which lacks both cytochrome bo 3 and cytochrome bd quinol oxidases (17) , was used as the host strain for expressing both the wild type and mutant cytochrome bd from a plasmid. To obtain wild type cytochrome bd, plasmid pTK1 (24) was introduced into the strain. Mutants of cytochrome bd were expressed using pTK1 plasmid as well. Phagemid pZG1 was used as the template for site-directed mutagenesis. This phagemid, prepared by Dr. Tamma Zuberi, was generated by ligating the cydA gene into phagemid pT7T3 19u using two unique restriction sites HindIII and SalI.
Site-directed Mutagenesis, Expression, and Complementation Test of the Mutant Cytochrome bd-Plasmid pZG1 (see above) was used as template. The oligonucleotide primers were synthesized by the University of Illinois Biotechnology Center and purified using oligonucleotide purification cartridges with melting temperature around 80°C based on the Stratagene formula. The mutagenesis was performed as described (24) . Once the mutant sequences were confirmed from DNA sequencing (CBI Inc.), the mutant plasmids were digested by restriction endonuclease SalI and HindIII. The digestions were then subjected to agarose gel electrophoresis. The bands containing DNA of cydA were cut from the gel, and DNA was extracted using "GenElute minus EtBr" columns (Sigma) and ligated to vector pTK1 that had been pretreated with the same restriction endonucleases. The resulting mutant cydAB operon was again confirmed from DNA sequencing (CBI Inc.). Complementation was tested as described previously (24) .
Cell Growth and Protein Sample Preparation-Large scale cell growth of strains that grow aerobicallly (i.e. expressing wild type or R391K mutant) was carried out in 24 2-liter flasks shaking at 230 rpm 37°C using an Innova 4330 incubator shaker (New Brunswick Scientific). Strains expressing the inactive mutants (e.g. R391A) could not be grown aerobically and were, therefore, grown in a 20-liter fermenter anaerobically at the Fermentation Facility at the University of Illinois using LB containing 100 g/ml Amp, 50 g/ml Kan, and 0.3% glucose, pH 7, at 37°C.
The mutant cytochrome bd oxidases were purified as described previously (24) . The pooled fractions were concentrated using an Amicon concentrator with a 50-kDa molecular weight cut-off filter and then dialyzed three times against 50 mM sodium phosphate buffer, pH 7.9, containing 5 mM EDTA, 0.05% N-lauroylsarcosine. Both wild type and mutant cytochrome bd samples were then examined, using the same dialysis buffer for appropriate dilution unless specified otherwise. All of these assays were carried out as described in Ref. 24 .
UV-visible Spectroscopic Measurements-All of the absorbance spectra in the UV-visible region were obtained with a DW2000 spectrophotometer (Aminco) or UV-2101PC spectrophotometer (Shimadzu) using a 1-cm path length cuvette. The absorbance spectra for midpoint potential measurements were obtained using an ultrathin layer spectroelectrochemical cell (25) with the UV-2101PC scanning spectrophotometer (Shimadzu).
FIG. 1.
Scheme of subunit I (CydA) of the cytochrome bd quinol oxidase from E. coli. The filled circles represent highly conserved residues, and the arrows point to the three known heme axial ligands and to the Arg 391 residue. The model has nine transmembrane helices, and the large "Q loop" has been implicated in quinol oxidation.
EPR Spectroscopic Measurements-X-band (9.09-GHz) EPR spectra were acquired on a Varian E-122 spectrometer with a modulation amplitude of 5 gauss at 100 kHz at 9 K. Samples were prepared as frozen glasses in 3-mm inner diameter tubes using an Air Product Helitran cryostat. The magnetic field was calibrated with a Varian NMR gauss meter, and the microwave frequency was determined by an EIP frequency meter (San Jose, CA). Spectra were recorded with ferricyanide-oxidized samples of the R391A mutant oxidase (30 M) at 9 K and a power of 1 milliwatt.
Difference Spectroscopy Showing Binding of CO-The R391A mutant oxidase (2.3 M) was made anaerobic by purging with argon gas for 1 h and was then reduced by adding fresh dithionite solution. The absorption spectrum of the reduced enzyme was recorded and taken as a base line. The sample was then purged with CO gas flow for 5 min, following which the absorbance spectrum was taken. The difference spectrum was generated by subtracting the spectrum of reduced enzyme from the one after binding CO.
Redox Titrations of Wild Type Cytochrome bd and the R391A Mutant-Both wild type and the Arg
391 mutant oxidases were prepared as described above. The redox titration was carried out using the ultrathin layer spectroelectrochemical cell for UV-visible spectroscopy as previously described (25) . The gold grid working electrode was chemically modified by 2 mM cysteamine solution as reported before (26) . In order to accelerate the redox reaction, 15 different mediators were added, as reported in Ref. 26 , to a total concentration of 40 M each. At this concentration and with the path length below 10 m, no spectral contribution from the mediators in the visible region could be detected in the control experiment with samples lacking the protein. As a supporting electrolyte, 100 mM KCl was added. Approximately 25-30 l of the protein sample was used to fill the spectroelectrochemical cell. Absorbance changes were monitored at multiple wavelengths using a UVPC-2101 spectrophotometer (Shimadzu). The equilibration time was less than 15 min under the conditions described above. Redox titrations were performed by stepwise setting the potentials and recording the spectra after sufficient equilibrations. All measurements were obtained at 10°C and were repeated at least twice. For the wild type enzyme, absorbance changes at 429, 560, and 628 nm were used to generate the heme titration curves. For the R391A mutant, due to the dilute concentration, absorbance changes at 628 nm were too small to generate an accurate curve. The midpoint potentials (E m ) were obtained by interactive fitting to a Nernst equation using the program offered by Origin (Microcal).
FTIR Measurements-Purified wild type enzyme (grown anaerobically) and the R391A mutant (20 M) were concentrated using a microconcentrator (Amicon, 50-kDa cut-off filter) by centrifugation using 50 mM sodium phosphate buffer, pH 8.3, 5 mM EDTA, 0.05% N-lauroyl sarcosine. FTIR and visible difference spectra as a function of the applied potential were obtained simultaneously from the same sample with a setup combining an IR beam from the interferometer (modified IFS 25; Bruker, Germany) for the 4000 to 1000 cm Ϫ1 range and a dispersive spectrometer for the 400 -900-nm range. Electrochemically induced difference spectra were recorded and processed as previously described in Ref. 25 . In all experiments, the protein solution was first equilibrated at the initial potential of the electrode, and single beam spectra in the IR range were recorded. Then a potential step toward the final potential was applied, and the single beam spectrum of this state was again recorded after equilibration. Subsequently, difference spectra, as presented in this work, were calculated from the two single beam spectra with the initial single beam spectrum taken as the reference. The equilibration at the applied potential generally took less than 5-6 min in the potential range from Ϫ0.3 to 0.7 V. Typically, 5 ϫ 128 scans were co-added, and 10 -20 spectra were averaged. No smoothing or deconvolution procedures were applied. The noise level in the difference spectra was estimated to be around 30 -50 ϫ 10 Ϫ6 absorbance units in the spectral range under consideration except for the region of the strongly absorbing water bending and protein amide I modes at ϳ1650 cm Ϫ1 , where the noise was slightly higher. HPLC Analysis of Quinone Content-Membranes from different growth conditions were isolated as previously described (27) , and small aliquots were homogenized using a buffer containing 25 mM Tris-HCl, 1 mM EDTA (disodium salt), pH 7.5. Either this membrane suspension or, alternatively, purified protein was prepared to contain 3-6 nmol of cytochrome bd in 500 l. Quinone was extracted by vortex-mixing 500 l of the sample with 3 ml of methanol/petroleum ether (v/v ratio 3:2) and centrifuged to collect the supernatant. The vortex and centrifuge step were repeated three times to ensure complete extraction of quinone. Supernatant containing extracted quinone was dried under nitrogen gas flow and quinone was redissolved in 100 l of ethanol just prior to HPLC injection. A BIO-CAD Sprint™ (PerSeptive Biosystems) HPLC and Microsorb-MV 100A HPLC column (Varian Analytical Instruments) were used. The running phase was 100% ethanol, and eluted material was monitored at 278 nm. The peak area was calculated, and the amount of quinone bound to the sample was obtained by comparing with the standard peak, in which the amount of UQ-10 added was known. The extraction efficiency was also taken into account 3 . FTIR difference spectra (fully oxidized minus fully reduced) of the wild type (WT; gray line) and R391A mutant oxidase (black line). The experimental details are provided under "Materials and Methods." The difference spectra were normalized based on difference spectra obtained in the visible spectral range. The two arrows indicate bands diagnostic of bound menaquinone and bound ubiquinone, which are evident in both spectra.
to get the real amount of quinone bound to the sample. To obtain the extraction efficiency factor, a known amount of UQ-10 (Sigma) was added both to the protein sample for extraction and directly to an HPLC column.
Anaerobic Reduction of the Enzyme by Ubiquinol-1-Enzyme solutions (about 5 M) were made anaerobic by purging the vapor phase with water-saturated argon gas for 1 h in a homemade anaerobic cuvette with a small stir bar stirring at the bottom. The reaction was initiated by the injection of a mixture of dithiothreitol and ubiquinol-1 to the cuvette to final concentrations of 2 mM and 400 M, respectively. A series of absorbance spectra were taken starting either before or right after the mixing using a photodiode array detector (from the BioSequential SX-17MV stopped-flow spectrophotometer; Applied Photophysics Ltd.) until no further changes could be observed.
Aerobic Reduction of the Enzyme by Menadiol-Enzyme solutions (about 10 M) were diluted 10-fold with the same dialysis buffer used for purification. The reaction was initiated by injecting a mixture of menadione and dithiothreitol to a final concentration of 330 M and 13.5 mM, respectively. A series of absorbance spectra were taken right before the mixing using an Agilent 8453 spectrophotometer (Agilent Technologies) with a cycling time of 0.5 s until no further changes could be observed.
CO Photolysis of the CO Adduct of Fully Reduced Enzyme-The purified wild type and R391A oxidases (about 5 M) were reduced by incubation with 100% carbon monoxide gas and dithionite solution. A gas mixture consisting of 1% CO and 99% argon was introduced to the gas-tight cuvette, which held the reduced sample until the 100% CO gas was fully replaced. A flash with a duration of several ms was obtained with a camera flash unit, followed immediately by recording of the UV-visible spectral changes of the sample using the photodiode array detector of the BioSequential SX-17MV stopped-flow spectrophotometer (Applied Photophysics) until no further changes were observed. Data were analyzed using the Matlab 6.1 program with 3.3 nm/point. The global multiexponential fittings for spectral changes between 300 and 800 nm were generated by the SplMod program (28) with the equation
. . , assuming a one-, two-, or three-phase process each time.
Oxidation of the Reduced Enzyme with O 2 -The purified R391A protein sample (about 5 M) was made anaerobic by purging with argon gas for 1 h in a gas-tight cuvette and was then was reduced by an equivalent amount of freshly made dithionite dissolved in the same buffer as used for the enzyme. Oxygen gas was introduced to the cuvette for 18 s once the sample was fully reduced. A series of spectra was taken during the reduction and oxidation using the photodiode array detector of the stopped-flow spectrophotometer (Applied Photophysics Ltd.).
RESULTS
Catalytic Activity, UV-visible, and EPR Spectroscopy-The R391A, R391Q, and R391M mutant oxidases were unable to sustain aerobic growth when expressed in a strain (GO105) lacking the wild type respiratory oxidases, and the purified oxidases had no ubiquinol oxidase activity (see Table I ). In contrast, the R391K mutant oxidase was able to support aerobic growth on plates as the only respiratory oxidase, and the purified enzyme exhibited 25% of the quinol oxidase activity compared with the wild type cytochrome bd (Table I) . In liquid culture, the aerobic growth of cells relying on the R391K mutant oxidase (i.e. expressed in the cyo Ϫ , cyd Ϫ strain) was very poor. Although lysine could partially substitute for arginine at this position in the structure, it is clear that simply having a positive charged residue at position 391 is not sufficient for robust growth.
Interestingly, the steady state oxidase activity using TMPD as the electron donor in place of ubiquinol was virtually unaffected by the mutations. It has been previously shown that TMPD donates electrons to the oxidase from a site distinct from that used by ubiquinol (23) . The fact that TMPD oxidase activity is not impaired by the mutations demonstrates that the active site for the reduction of O 2 (i.e. heme b 595 /heme d binuclear center) is fully functional in these mutants.
The heme analysis and the UV-visible reduced minus oxidized difference spectra of each of the purified mutant oxidases indicate no substantial differences compared with the wild type enzyme (Table I and Fig. 2 ). The R391A mutant was selected as representative of the set of mutants and subjected to more detailed examination. The EPR spectrum of the fully oxidized R391A mutant oxidase was found to be essentially identical to the spectrum of the wild type oxidase (not shown). This similarity includes the unusual highly asymmetric low spin spectral feature near g ϭ 3.5 arising from the low spin heme b 558 component of the oxidase (29) .
These studies show that the mutations do not perturb the assembly of the enzyme or result in a gross conformational change of the enzyme and do not perturb the local structure around any of the three heme prosthetic groups to the extent that the EPR or UV-visible spectra are altered.
CO Binding to Heme d-Another useful probe of perturbations caused by the Arg
391 mutants is the binding of CO to the oxidase. CO binds to the ferrous heme d component of the enzyme. Spectroscopic changes to the hemes were monitored upon titrating CO into a solution of the dithionite-reduced R391A and wild type oxidases. The changes induced by CO binding are identical for the two enzymes (not shown). In addition, CO was photodissociated from the enzyme, and the recombination kinetics was examined. In each case, the recombination kinetics (not shown) are biphasic, with rates of 266 s FTIR Oxidized Minus Reduced Difference Spectroscopy-The oxidized minus reduced (Ϫ0.3 to ϩ0.7 V) FTIR difference spectrum (1800 to 1200 cm Ϫ1 ) of the wild type, R391K, and R391A mutant oxidases were recorded and compared. Fig. 3 compares the difference spectra of the wild type and R391A oxidases. The amplitudes have been normalized based on spectra measured in the visible spectral range. The spectra of both mutants are very similar to that of the wild type enzyme, consistent with the conclusion that the mutations do not result in any large conformational changes. The bands previously assigned (30) to menaquinone (1264 cm Ϫ1 ) and ubiquinone (1295 cm Ϫ1 ) are both present in the spectra of the mutants (arrows in Fig. 3) . Small variations indicate differences in quinone ratio in accordance with Ref. 30 . The quinones were extracted from the isolated wild type and R391A oxidases and analyzed by HPLC chromatography. The results were consistent with the FTIR
FIG. 5. Potentiometric titrations of the wild type oxidase monitored at 429 nm (A), 560 nm (B), and 628 nm (C).
The lines are fits to the experimental points using the Nernst equation. The trace at 429 nm is fit to three components at ϩ60, ϩ240, and ϩ260 mV. The component at ϩ60 mV is due to heme b 558 , and the high potential components are due to heme b 595 and heme d. The trace at 560 nm is fit to two components with midpoints at ϩ80 mV (heme b 558 ) and ϩ222 mV (heme b 595 ). The trace at 628 nm is fit to one component with a midpoint at ϩ253 mV (heme d).
FIG. 6. Potentiometric titration of the R391A mutant oxidase monitored at 429 nm (A) and 560 nm (B).
The trace at 429 nm has three components with midpoints at Ϫ132, ϩ20, and ϩ259 mV. The component at Ϫ132 mV is assigned as being due to heme b 558 , and that at ϩ20 is due to heme b 595 and, perhaps, heme d. The small component with a high midpoint potential (ϩ259 mV) is not assigned. The trace at 560 nm has components corresponding to heme b 558 (Ϫ121 mV) and heme b 595 (ϩ37 mV), similar to the two major components observed at 429 nm. The midpoint potential of heme d could not be deciphered due to small absorption at 628 nm. spectroscopy and indicated that both ubiquinone and menaquinone co-purify with the enzymes (data not shown).
Potentiometric Titrations of the Wild Type and R391A Oxidases-The electrochemical properties of the oxidase are greatly perturbed by the R391A mutation. This can be seen in Fig. 4 , which shows the UV-visible difference spectra for the enzymes at different redox cuts at pH 8.3. For the wild type oxidase (Fig. 4A) , the enzyme is fully reduced at Ϫ342 mV (NHE) and at 0 mV (NHE). The enzyme is fully oxidized at ϩ558 mV (NHE), as shown by the difference spectrum. The R391A mutant behaves very differently. As shown in Fig. 4B , there is considerable oxidation of the enzyme at 0 mV (NHE). It appears that about 70% of heme d and probably all of heme b 558 are oxidized at 0 mV. The status of heme b 595 is not clear from these spectra.
Full electrochemical titrations were performed and monitored at 429, 560, and 628 nm. Figs. 5 and 6 show representative plots of absorbance versus solution potential for the wild type (Fig. 5 ) and the R391A mutant (Fig. 6) . The electrochemical properties of the wild type enzyme are similar to those reported previously (31) : heme b 558 , ϩ60 to ϩ80 mV; heme b 595 , ϩ220 to ϩ240 mV; heme d, ϩ250 to ϩ260 mV. For the R391A mutant oxidase, the midpoint potentials of heme b 558 and heme b 595 are shifted downward dramatically: heme b 558 , Ϫ132 to Ϫ121 mV; heme b 595 , ϩ20 to ϩ37 mV. The midpoint potential of heme d was not determined because the sample concentration was insufficient to obtain a sufficient absorption at 628 nm. However, the spectra in Fig. 4 clearly show that about two-thirds of heme d is reduced at 0 mV, which is consistent with a midpoint potential considerably lower than ϩ250 mV as in the wild type oxidase. Probably, the midpoint potential of heme d is close to that of heme b 595 in the mutant.
An electrochemical redox titration was also performed on the R391K mutant oxidase. The midpoint potentials of the three hemes were found to be essentially the same as those of the wild type enzyme (data not shown), which is consistent with the observation that this mutant is partially active and able to complement the aerobic growth of oxidase-deficient E. coli strain GO105.
Kinetics of Reduction of the Enzyme by Ubiquinol under Anaerobic
Conditions-Under anaerobic conditions, the wild type oxidase can be reduced upon the addition of the substrate, ubiquinol-1, plus dithiothreitol to keep the substrate fully re- The reduction of the enzyme (about 1 M) was monitored at 560 nm and was carried out under aerobic conditions. The conditions are given under "Results." The wild type oxidase is reduced within a few seconds after adding the substrate, presumably after the oxygen has been depleted. The mutant oxidase is reduced at least 80-fold more slowly.
duced. The rate of this reaction is, however, very slow and multiphasic, with the fastest rate constant being about 0.3 s Ϫ1 . This is much slower than turnover, which is on the order of 1000 s Ϫ1 . Hence, the slow reduction of the enzyme by ubiquinol-1 under anaerobic conditions must represent a reaction unrelated to catalytic function. Under the same conditions, the Arg 391 mutants are all reduced in a similar manner. The shifted midpoint potential of heme b 558 does not impede the reaction, which is driven by the presence of dithiothreitol, which has a midpoint potential of Ϫ330 mV (NHE). The dithiothreitol itself does not reduce the enzyme. Representative data are shown in Fig. 7 .
More informative is the reaction of menadiol with the oxidase (Fig. 8) . The wild type enzyme in the presence of menadiol under aerobic conditions rapidly turns over and depletes the oxygen in solution and is then fully reduced in a matter of a few seconds. In contrast, the R391A mutant oxidase is not substantially reduced by menadiol under the same conditions. These data are consistent with the large drop of the midpoint potential of heme b 558 to a point where it is not significantly reduced by menadiol.
Kinetics of Oxidation of the Fully Reduced Enzyme by O 2 -
The fact that the Arg 391 mutants all have TMPD oxidase activity implies that the oxygen reactive site is not perturbed greatly, if at all, by these mutations. This was confirmed also by adding O 2 to dithionite-reduced enzyme and monitoring the oxidation of the hemes optically. For both the wild type and mutants, the reaction is rapid and goes to completion (not shown). Rates were not determined using rapid mixing, but qualitatively, the kinetic traces appear identical.
DISCUSSION
Arg 391 , although not totally conserved, is present in the vast majority of sequences of CydA. Since it is only two residues away from Met 393 , which has been shown to be an axial ligand to heme b 558 (17) , it is reasonable to speculate that Arg 391 might be important in determining the properties of this heme component of the enzyme. The current work confirms this speculation. Whereas the R391K mutant retains substantial catalytic function, substitution by a neutral residue (Ala, Met, or Gln) eliminates quinol oxidase activity. UV-visible, EPR, and FTIR spectroscopies show no significant alteration of the enzyme structure of these inactive mutants. The mutant enzymes all retain TMPD oxidase activity, and the reduced enzymes are rapidly and fully reoxidized by O 2 , which suggests that the mutants do not disable the heme b 595 /heme d binuclear site.
One major effect of the R391A mutation is the large shift of the electrochemical midpoint potential of heme b 558 from about ϩ80 to Ϫ132 mV (NHE). This is a shift in the direction one would predict from removing a positive charge in the immediate vicinity of heme b 558 . Indeed, the midpoint potential of heme b 558 in the R391K mutant, which retains the positive charge, is identical to that of the wild type oxidase. The low midpoint potential of heme b 558 in the R391A mutant would be expected to make it more difficult for the quinol substrates to reduce heme b 558 , which is clearly observed with menadiol as the substrate (Fig. 8) . As expected from the electrochemical studies, the R391K mutant oxidase reacts with menadiol in the same way as does the wild type oxidase. The unusually slow reduction of the wild type enzyme by ubiquinol-1 under anaerobic conditions (Fig. 7) is not relevant to turnover and is not understood. The data are not informative about the effects of the Arg 391 mutants on the enzyme, and further studies are required to clarify this reaction.
Surprisingly and significantly, the R391A mutation also results in substantially lower midpoint potentials of heme d (Fig.   4) and heme b 595 (Fig. 6) . It might be argued that the large drop of the midpoint potential of heme b 558 caused by the R391A mutation slows down the rate of internal electron transfer to heme d and heme b 595 and, therefore, results in the appearance of these hemes also having abnormally low midpoint potentials (i.e. they do not readily reduce). However, this cannot be the case, since one of the mediators present in the solution is TMPD, and it is clear that hemes d and b 595 readily react with TMPD. Possibly, Arg 391 may be critically placed to have an electrostatic influence on all three of the heme components. It is known that all three hemes are located on the periplasmic side of the membrane (15) , and the heme b 595 /heme d binuclear center must be close to heme b 558 to facilitate electron transfer from the bound quinol to each heme center (32) .
Previous work has strongly suggested that the quinone binding site is near heme b 558 (1, 13, 14) . A quinone-like inhibitor, decyl-aurachin D, results in shifting the midpoint potential of heme b 558 to much higher values and also eliminates quinol oxidase activity while not inhibiting TMPD oxidase activity. Hence, it is possible that the Arg 391 mutants may also be perturbing the quinol binding site (similar to decyl-aurachin D) and that this may be the primary cause for the loss of quinol oxidase activity. Another possibility is that the Arg 391 mutations might destabilize the semiquinone intermediate, presumably required for function (33) . The FTIR difference spectrum of the R391A mutant shows that both ubiquinone and menaquinone remain bound to the enzyme, and HPLC analysis shows quinone co-purifying with the enzyme. Hence, the mutations probably do not prevent quinol binding per se. A determination of whether the R391A mutant influences the orientation of the bound quinol or the stability of the semiquinone will require further experimentation.
The R391A mutant is reduced anaerobically by ubiquinol-1 at a rate similar to the wild type oxidase. However, the reduction of the oxidase by reduced ubiquinol is very slow (k Ͻ 0.3 s Ϫ1 ) even with the wild type enzyme, and this process cannot be directly related to the reactions occurring during turnover (1000 s Ϫ1 ). In the kinetic mechanism proposed by Jü nemann et al. (32) , it is predicted that the species that reacts rapidly with quinol is actually the transiently formed one-electron reduced form of the enzyme with ferrous heme b 558 . If this is correct, then perhaps the reaction of ubiquinol with the fully oxidized enzyme would be much slower, as observed here. However, the R391A mutant dramatically slows down the reduction of cytochrome bd by an alternate substrate, menadiol, a soluble analogue of menaquinone (Fig. 8) . This is consistent with the lack of quinol oxidase activity by the enzyme. Further studies are required to clarify whether the R391A mutant perturbs quinol binding to the enzyme in addition to influencing the heme electrochemical properties.
The simplest conclusion is that the substitution of Arg 391 by a neutral residue abolishes quinol oxidation activity primarily due to a large shift in the midpoint potential of heme b 558 . There are variants of cytochrome bd in which Arg 391 is not conserved, mostly in thermophilic microorganisms and in Bacillales. In one of the sequences from B. subtilis, for example, the Arg 391 position is occupied by asparagine. Presumably, the reduced form of heme b 558 is stabilized by the interaction with a positively charged residue at another position but still close to the heme. Alternatively, some of these organisms may utilize substrates with considerably lower midpoint potentials.
